Ozeroff Christopher David
Related Filers (1)
Ownership (20)
4
Thursday, 12/16/2021
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/23/2021
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/23/2020
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/5/2017
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/1/2017
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2017
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/21/2016
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2016
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/6/2016
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2016
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/21/2015
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/17/2015
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/3/2014
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/19/2013
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/24/2012
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/24/2011
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/7/2010
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/28/2010
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/22/2010
ARCA biopharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/5/2009
ARCA biopharma, Inc.: Initial statement of beneficial ownership of securities